Ignite Creation Date:
2024-05-06 @ 3:24 PM
Last Modification Date:
2024-10-26 @ 1:49 PM
Study NCT ID:
NCT04624399
Status:
RECRUITING
Last Update Posted:
2022-08-12
First Post:
2020-11-05
Brief Title:
Neoadjuvant Immune Checkpoint Inhibitor Treatment in Urothelial Cancer
Sponsor:
Queen Mary University of London
Organization:
Queen Mary University of London
Organization Data
Organization:
Queen Mary University of London
Class:
OTHER
Study ID:
ABACUS-2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Queen Mary University of London
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Hoffmann-La Roche | INDUSTRY |